Hydrogen sulfide in hemostasis: Friend or foe?

Chemico-Biological Interactions

Volumn 217, Issue , 2014, Pages 49-56

  Olas, Beata ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Blood platelet activation; Cardiovascular system; Hemostasis; Hydrogen sulfide

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; CARBON MONOXIDE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; HOMOCYSTEINE; HYDROGEN SULFIDE; NITRIC OXIDE; SULFURTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CROHN DISEASE; DRUG MECHANISM; HEMOSTASIS; HUMAN; KIDNEY INJURY; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE; ULCERATIVE COLITIS; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD PLATELET ACTIVATION; ENZYMOLOGY; SIGNAL TRANSDUCTION;

BLOOD PLATELET ACTIVATION; CARDIOVASCULAR SYSTEM; HEMOSTASIS; HYDROGEN SULFIDE;

ANIMALS; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; CYSTEINE; HEMOSTASIS; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

EID: 84899856821     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.04.006     Document Type: Review

References (98)

1. C. Szabo Hydrogen sulfide and its therapeutic potential Nat. Rev. Drug Discov. 6 2007 917 935
2. E. Grambow, F. Mueller-Graf, E. Delyagina, M. Frank, A. Kuhla, and B. Vollmar Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice Platelets 25 2014 166 174
3. A.J. Ellis, and N.B. Milestone The ionization constants of hydrogen sulphide from 20 to 90°C Geochim. Cosmochim. Acta 31 1967 615 620
4. M.N. Huges, M.N. Centelles, and K.P. Moore Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review Free Radic. Biol. Med. 47 2009 1346 1353
5. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii, and H. Kimura A source of hydrogen sulfide and a mechanism of its release in the brain Antioxid. Redox Signal. 11 2009 205 214
6. R. Wang The gasotransmitter role of hydrogen sulfide Antioxid. Redox Signal. 5 2003 493 501
7. L. Moore, and P.K. Li Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol. Sci. 29 2008 84 90
8. K. Abe, and H. Kimura The possible role of hydrogen sulfide as an endogenous neuromodulator J. Neurosci. 16 1996 1066 1071
9. M. Whiteman, and P.K. Moore Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide J. Cell. Mol. Med. 13 2009 488 507
10. P.J. Hogg Contribution of allosteric disulfide bonds to regulation of hemostasis J. Thromb. Haemost. 7 Suppl. 1 2009 13 16
11. W. Zhao, J. Zhang, Y. Lu, and R. Wang The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener EMBO J. 20 2001 6008 6016
12. M. Whiteman, N. Cheung, Y. Zhu, S.H. Chu, J.L. Siau, B.S. Wong, J.S. Armstrong, and P.K. Moore Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? BBRC 326 2005 794 798
13. D.J. Elsey, R.C. Fowkes, and G.F. Baxter Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S) Cell Biochem. Funct. 28 2010 95 106
14. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii, and H. Kimura A source of hydrogen sulfide and a mechanism of its release in the brain Antioxid. Redox Signal. 11 2009 205 214
15. 2S) - the third gas of interest for pharmacologists Pharmacol. Rep. 59 2007 4 24
16. 2S be the third endogenous gaseous transmitter? FASEB J. 16 2002 1792 1798
17. 2S: a "double face" molecule in health and disease Biofactors 39 2013 186 196
18. N. Shibuya, S. Koike, M. Tanaka, M. Ishigami-Yuasa, Y. Kimura, Y. Ogasawara, K. Fukui, N. Nagahara, and H. Kimura A novel pathway for the production of hydrogen sulfide from d-cysteine in mammalian cells Nat. Commun. 4 2013 1366
19. 2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine J. Biol. Chem. 279 2004 52082 52086
20. 2S by 3-mercaptopyruvate sulphurtransferase J. Biochem. 149 4 2011 357 359
21. N. Shibuya, M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, K. Ishii, and H. Kimura 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain Antioxid. Redox Signal. 11 2009 703 714
22. N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara, and H. Kimura Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide J. Biochem. 146 2009 623 626
23. Y. Ogasawara, S. Isoda, and S. Tanable Tissue and subcellular distribution of bound and acid-labile sulfur; and the enzymatic capacity for sulfide production in the rat Biol. Pharm. Bull. 17 1994 1535 1542
24. L. Kram, E. Grambow, F. Mueller-Graf, H. Sorg, and B. Vollmar The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases Thromb. Res. 132 2013 e112 e117
25. E.G. Mueller Trafficking in persulfides: delivering sulfur in biosynthetic pathways Nat. Chem. Biol. 2 2006 185 195
26. H.A. Beinert A tribute to sulfur Eur. J. Biochem. 267 2000 5657 5664
27. J.I. Toohey Sulfur signaling: is the agent sulfide or sulfane? Anal. Biochem. 413 2011 1 7
28. L. Li, and P.K. Moore An overview of the biological significance of endogenous gases: new role for old molecules Biochem. Soc. Trans. 35 2007 1138 1141
29. R.C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J.L. Wallace Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation FASEB J. 20 2006 2118 2120
30. A. Sivarajah, M. Collino, M. Yasin, E. Benetti, M. Gallicchio, E. Mazzon, S. Cuzzocrea, R. Fantozzi, and C. Thiemermann Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of reginal myosardial I/R Shock 31 2009 267 274
31. F.S. Gaskin, K. Kamada, M. Yusof, W. Durante, G. Gross, and R.J. Korthuis AICAR preconditioning prevents postischemic leukocyte rolling and adhesion: role of K(ATP) channels and heme oxygenase Microcirculation 16 2009 167 176
32. M. Bhatia, J. Sidhapuriwala, S.M. Moochhala, and P.K. Moore Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat Br. J. Pharmacol. 145 2005 141 144
33. J. Du, Y. Hui, Y. Cheung, G. Ben, H. Jiang, X. Chen, and C. Tang The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells Heart Vessels 19 2004 75 80
34. G.S. Oh, H.O. Pae, B.S. Lee, B.N. Kim, J.M. Kim, H.R. Kim, S.B. Jeon, W.K. Jeon, H.J. Chae, and H.T. Chung Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide Free Radic. Biol. Med. 41 2006 106 119
35. S.O. Jeong, H.O. Pae, G.S. Oh, G.S. Jeong, B.S. Lee, S. Lee, D.Y. Kim, H.Y. Rhew, K.M. Lee, and H.T. Chung Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells Biochem. Biophys. Res. Commun. 345 2006 938 944
36. S. Fiorucci, E. Antonelli, E. Distrutti, G. Rizzo, A. Mancarelli, S. Orlandi, R. Zanardo, B. Renga, M. Di Sante, A. Morelli, G. Cirino, and J.L. Wallace Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs Gastroenterology 129 2005 1210 1224
37. G. Zagli, R. Patacchini, M. Trevisani, R. Abbate, S. Cinotti, G.F. Gensini, G. Masotti, and P. Geppetti Hydrogen sulfide inhibits human platelet aggregation Eur. J. Pharmacol. 559 2007 65 68
38. R. Hosoki, N. Matsuki, and H. Kimura The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide Biochem. Biophys. Res. Commun. 237 1997 527 531
39. 2S-dependent cardiac effects in frog and rat Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 2013 R443 R451
40. I. Castro-Piedras, and J.F. Perez-Zoghbi Hydrogen sulphide inhibits Ca2+ release through InsP3 receptors and relaxes airway smooth muscle J. Physiol. 591 2014 5999 6015
41. 2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder Br. J. Pharmacol. 142 2004 31 34
42. K. Qu, C.P. Chen, B. Halliwell, P.K. Moore, and P.T. Wong Hydrogen sulfide is a mediator of cerebral ischemic damage Stroke 37 2006 889 893
43. P.T. Wong, K. Qu, G.N. Chimon, A.B. Seah, H.M. Chang, M.C. Wong, Y.K. Ng, H. Rumpel, B. Halliwell, and C.P. Chen High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide J. Neuropathol. Exp. Neurol. 65 2006 109 115
44. P. Kamoun Mental retardation in Down syndrome: a hydrogen sulfide hypothesis Med. Hypotheses 57 2001 389 392
45. M. Whiteman, J.S. Armstrong, S.H. Chu, S. Jia-Ling, B.S. Wong, N.S. Cheung, B. Halliwell, and P.K. Moore The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J. Neurochem. 90 2004 765 768
46. M. Whiteman, N.S. Cheung, Y.Z. Zhu, S.H. Chu, J.L. Siau, B.S. Wong, J.S. Armstrong, and P.K. Moore Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem. Biophys. Res. Commun. 326 2005 794 798
47. M. Collin, and C. Thiemermann Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation Shock 24 2005 595 596
48. H. Mitsuhashi, H. Ikeuchi, and Y. Nojima Is sulfite an antiatherogenic compound in wine? Clin. Chem. 47 2001 1872 1873
49. S.K. Austin Haemostasis Medicine 37 2009 133 136
50. H. Nishikawa, H. Hayashi, S. Kubo, M. Tsubota-Matsunami, F. Sekiguchi, and A. Kawabata Inhibition by hydrogen sulfide of rabbit platelet aggregation and calcium mobilization Biol. Pharm. Bull. 36 2013 1278 1282
51. A. Morel, J. Malinowska, and B. Olas Antioxidative properties of hydrogen sulfide may involve in its antiadhesive action on blood platelets Clin. Biochem. 45 18 2012 1678 1682
52. A. Morel, J. Malinowska, and B. Olas Hydrogen sulfide changes adhesive properties of fibrinogen and collagen in vitro Platelets 25 2014 147 149
53. B. Chadefaux, I. Ceballos, M. Hamet, M. Coude, M. Poissonnier, P. Kamoun, and D. Allard Is absence of atheroma in Down syndrome due to decreased homocysteine levels? Lancet 2 1988 741
54. S.E. Rittenhouse Phosphoinositide 3-kinase activation and platelet function Blood 12 1996 4401 4414
55. J. Zhang, S.J. Shattil, M.C. Cunningham, and S.E. Rittenhouse Phosphoinositide 3-kinase γ and p85/phosphoinositide 3-kinase in platelets J. Biol. Chem. 271 1996 6265 6272
56. B. Wachowicz, B. Olas, H.M. Zbikowska, and A. Buczynski Generation of reactive oxygen species in blood platelets Platelets 13 2002 175 182
57. Y. Hu, X. Chen, T.T. Pan, K.L. Neo, S.W. Lee, E.S. Khin, P.K. Moore, and J.S. Bian Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways Pflugers Arch. 455 2008 607 616
58. B. Olas, B. Kontek, The possible role of hydrogen sulfide as a modulator of hemostatic properties of plasma. Chem-Biol. Inter. (sub.).
59. L. Li, P. Rose, and P.K. Moore Hydrogen sulphide and cell signaling Annu. Rev. Pharmacol. Toxicol. 109 2011 169 187
60. R. Marchi, Z. Carvajal, and J.W. Weisel Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen Thromb. Haemost. 99 2008 451 452
61. I.L. Quintana, M.V. Oberholzer, L. Kordich, and A.M. Lauricella Impaired fibrin gel permeability by high homocysteine levels Thromb. Res. 127 2011 35 38
62. H. Yan, J. Du, and C. Tang The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats Biochem. Biophys. Res. Commun. 313 2004 22 27
63. G. Zhong, F. Chen, Y. Cheng, C. Tang, and J. Du The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase J. Hypertens. 21 2003 1879 1885
64. M.Y. Ali, C.Y. Ping, Y.Y. Mok, L. Ling, M. Whiteman, M. Bhatia, and P.K. Moore Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br. J. Pharmacol. 149 2006 625 634
65. Y.Z. Zhu, Z.J. Wang, P. Ho, Y.Y. Loke, Y.C. Zhu, S.H. Huang, C.S. Tan, M. Whiteman, J. Lu, and P.K. Moore Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats J. Appl. Physiol. 102 2007 261 268
66. 2-dependent manner Am. J. Physiol. Heart Circ. Physiol. 292 2007 H1953 H1960
67. B.L. Predmore, D. Julian, and A.J. Cardounel Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism Front. Physiol. 2 2011 104
68. S. Minamishima, M. Bougaki, P.Y. Sips, J.D. Yu, Y.A. Minamishima, J.W. Elrod, D.J. Lefer, K.D. Bloch, and F. Ichinose Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice Circulation 120 2009 888 896
69. K. Issa, A. Kimmoun, S. Collin, F. Ganster, S. Fremont-Orlowski, P. Asfar, P.M. Mertes, and B. Levy Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury Crit. Care 17 2013 1 12
70. Y.E. Huang, Z.H. Tang, W. Xie, X.T. Shen, M.H. Liu, X.P. Peng, Z.Z. Zhao, D.B. Nie, L.S. Liu, and Z.S. Jiang Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase Exp. Ther. Med. 4 2012 1117 1123
71. W.H. Sun, F. Liu, Y. Chen, and Y.C. Zhu Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion Biochem. Biophys. Res. Commun. 421 2012 164 169
72. J. Du, Y. Hui, Y. Cheung, G. Bin, H. Jiang, X. Chen, and C. Tang The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells Heart Vessels 19 2004 75 80
73. G. Yang, X. Sun, and R. Wang Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3 FASEB J. 18 2004 1782 1784
74. 2S on human aorta smooth muscle cells FASEB J. 20 2006 553 555
75. E. Zavaczki, V. Jeney, A. Agarwal, A. Zarjou, M. Oros, M. Katko, Z. Varga, G. Balla, and J. Balla Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells Kidney Int. 80 2011 731 739
76. S. Mani, H. Li, A. Untereiner, L. Wu, G. Yang, R.C. Austrin, J.G. Dickhout, S. Lhotak, Q.H. Meng, and R. Wang Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis Circulation 127 2013 2523 2534
77. J. Ma, M.J. Stampfer, C.H. Hennekens, P. Frosst, J. Selhub, J. Horsford, M.R. Malinow, W.C. Willett, and R. Rozen Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians Circulation 94 1996 2410 2416
78. D.W. Jacobsen Hyperhomocysteinemia and oxidative stress: time for a reality check? Arterioscler. Thromb. Vasc. Biol. 20 2000 1182 1184
79. P. Kamoun, M.C. Belardinelli, A. Chabli, K. Lallouchi, and B. Chadefaux-Vekemans Endogenous hydrogen sulfide overproduction in Down syndrome Am. J. Med. Genet. A 116A 2003 310 311
80. S.K. Yan, T. Chang, H. Wang, L. Wu, R. Wang, and Q.H. Meng Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cell Biochem. Biophys. Res. Commun. 351 2006 485 491
81. L. Chang, B. Geng, F. Yu, J. Zhao, H. Jiang, J. Du, and C. Tang Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats Amino Acids 34 2008 573 585
82. B.L. Predmore, and D.J. Lefer Development of hydrogen sulphide-based therapeutics for cardiovascular diseases J. Cardiovasc. Transl. Res. 3 2010 487 498
83. S.C. Chuah, P.K. Moore, and Y.Z. Zhu S-allylcysteine mediates cardioprotection on an acute myocardial infarction rat model via a hydrogen sulphide-mediated pathway Am. J. Physiol. Heart Circ. Physiol. 293 2007 H2693 H2701
84. G. Scharbert, M.L. Kalb, M. Duris, C. Marschalak, and S.A. Kozek-Langenecker Garlic at dietary doses not impair platelet function Anesth. Analg. 105 2007 1214 1218
85. O. Kabil, and R. Banerjee Redox biochemistry of hydrogen sulfide J. Biol. Chem. 285 2010 21903 21907
86. C.A. Wagner Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator J. Nephrol. 22 2009 173 176
87. B. Deplancke, and H.R. Gaskins Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells FASEB J. 17 2003 1310 1312
88. 2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1 J. Biol. Chem. 279 2004 49199 49205
89. L. Rinaldi, G. Gobbi, M. Pambianco, C. Micheloni, P. Mirandola, and M. Vitale Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3 Lab. Invest. 86 2006 391 397
90. J. Lyons, A. Rauh-Pfeiffer, Y. Ming-Yu, X.M. Lu, D. Zurakowski, M. Curley, S. Collier, C. Duggan, S. Nurko, J. Thompson, A. Ajami, S. Borgonha, V.R. Young, and L. Castillo Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients Crit. Care Med. 29 2001 870 877
91. E. Disrutti, L. Sediari, A. Mencarelli, B. Renga, S. Orlandi, G. Russo, G. Caliendo, V. Santagada, G. Crino, J.L. Wallece, and S. Fiorucci 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity JPET 319 2006 447 458
92. S. Fiorucci, S. Orlandi, A. Mencarelli, G. Caliendo, V. Santagada, E. Distrutti, L. Santucci, G. Cirino, and J.L. Wallace Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis Br. J. Pharmacol. 150 2007 996 1002
93. L. Li, M. Salto-Tellez, C. Tan, M. Whiteman, and P.K. Moore GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat Free Radic. Biol. Med. 47 2009 103 113
94. 2S-releasing aspiryn Free Radic. Biol. Med. 46 2009 586 592
95. J.L. Wallace, G. Caliendo, V. Santagada, and G. Cirino Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) Br. J. Pharmacol. 159 2010 1236 1246
96. M. Iciek, A. Bilska, L. Ksiazek, Z. Srebro, and L. Wlodek Allyl disulfide as donor and cyanide as acceptor of sulfane sulfur in the mouse tissues Pharmacol. Rep. 57 2005 212 218
97. M.H. Stipanuk Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine Annu. Rev. Nutr. 24 2004 539 577
98. W. Qiao, T. Chaoshu, J. Hongfang, and D. Junbao Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis Biochem. Biophys. Res. Commun. 396 2010 182 186